Document Detail


Habitual dietary sodium intake is inversely associated with coronary flow reserve in middle-aged male twins.
MedLine Citation:
PMID:  22258268     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Evidence links dietary sodium to hypertension and cardiovascular disease (CVD), but investigation of its influence on cardiovascular function is limited.
OBJECTIVE: We examined the relation between habitual dietary sodium and coronary flow reserve (CFR), which is a measure of overall coronary vasodilator capacity and microvascular function. We hypothesized that increased sodium consumption is associated with lower CFR.
DESIGN: Habitual daily sodium intake for the previous 12 mo was measured in 286 male middle-aged twins (133 monozygotic and dizygotic pairs and 20 unpaired twins) by using the Willett food-frequency questionnaire. CFR was measured by positron emission tomography [N(13)]-ammonia, with quantitation of myocardial blood flow at rest and after adenosine stress. Mixed-effects regression analysis was used to assess the association between dietary sodium and CFR.
RESULTS: An increase in dietary sodium of 1000 mg/d was associated with a 10.0% lower CFR (95% CI: -17.0%, -2.5%) after adjustment for demographic, lifestyle, nutritional, and CVD risk factors (P = 0.01). Across quintiles of sodium consumption, dietary sodium was inversely associated with CFR (P-trend = 0.03), with the top quintile (>1456 mg/d) having a 20% lower CFR than the bottom quintile (<732 mg /d). This association also persisted within pairs: a 1000-mg/d difference in dietary sodium between brothers was associated with a 10.3% difference in CFR after adjustment for potential confounders (P = 0.02).
CONCLUSIONS: Habitual dietary sodium is inversely associated with CFR independent of CVD risk factors and shared familial and genetic factors. Our study suggests a potential novel mechanism for the adverse effects of dietary sodium on the cardiovascular system. This trial was registered at clinicaltrials.gov as NCT00017836.
Authors:
Silvia C Eufinger; John Votaw; Tracy Faber; Thomas R Ziegler; Jack Goldberg; J Douglas Bremner; Viola Vaccarino
Related Documents :
1778658 - Adipose tissue distribution changes during rapid weight loss in obese adults.
15311218 - The effect of the dietary supplement, chitosan, on body weight: a randomised controlled...
6393108 - A clinical assessment of modifast in u.k. general practice.
12566138 - Low-fat diets are preferred.
6271368 - Effects of a methyl-deficient diet on rat liver phosphatidylcholine biosynthesis.
20023128 - Effect of beta-glucans contained in barley- and oat-based diets and exogenous enzyme su...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Twin Study     Date:  2012-01-18
Journal Detail:
Title:  The American journal of clinical nutrition     Volume:  95     ISSN:  1938-3207     ISO Abbreviation:  Am. J. Clin. Nutr.     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-02-21     Completed Date:  2012-04-09     Revised Date:  2012-04-23    
Medline Journal Info:
Nlm Unique ID:  0376027     Medline TA:  Am J Clin Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  572-9     Citation Subset:  AIM; IM    
Affiliation:
Nutrition and Health Sciences Program, Emory University, Atlanta, GA 30322, USA.
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00017836
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine / metabolism
Cardiovascular Diseases / physiopathology,  prevention & control
Food Habits*
Fractional Flow Reserve, Myocardial / drug effects*
Humans
Hypertension / physiopathology,  prevention & control
Life Style
Linear Models
Male
Middle Aged
Nutrition Assessment
Positron-Emission Tomography / methods
Questionnaires
Risk Factors
Sodium, Dietary / administration & dosage*,  adverse effects*
Twins
Grant Support
ID/Acronym/Agency:
F31 HL107080/HL/NHLBI NIH HHS; F31HL107080/HL/NHLBI NIH HHS; K24 HL077506/HL/NHLBI NIH HHS; K24 MH076955/MH/NIMH NIH HHS; K24 RR023356/RR/NCRR NIH HHS; M01-RR00039/RR/NCRR NIH HHS; R01 AG026255/AG/NIA NIH HHS; R01 HL68630/HL/NHLBI NIH HHS; T32 MH067547/MH/NIMH NIH HHS; UL1 RR025008/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Sodium, Dietary; 58-61-7/Adenosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Beverage consumption, appetite, and energy intake: what did you expect?
Next Document:  A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial rand...